NCT02639013 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Hunt L, Frost SA, Hillman K, Newton PJ, Davidson PM
Management of intra-abdominal hypertension and abdominal compartment syndrome: a review. J Trauma Manag Outcomes. 2014 Feb 5;8(1):2. doi: 10.1186/1752-2897-8-2.
Newcombe J, Mathur M, Bahjri K, Ejike JC
Pediatric critical care nurses' experience with abdominal compartment syndrome. Ann Intensive Care. 2012 Jul 5;2 Suppl 1:S6. doi: 10.1186/2110-5820-2-S1-S6. Epub 2012 Jul 5.

Temporal Trend Analysis of Nurse's Knowledge and Practice Before and After Implementing an Educational Program Regarding Abdominal Compartment Syndrome

Details for clinical trial NCT02639013

Clinical trial NCT02639013 - References